BIOMAT Database Logo BIOMAT Database Logo

Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. 1990

L J Wheat, and P A Connolly-Stringfield, and R L Baker, and M F Curfman, and M E Eads, and K S Israel, and S A Norris, and D H Webb, and M L Zeckel
Indiana University School of Medicine, Indianapolis.

Histoplasmosis is a serious opportunistic infection in patients with AIDS, often representing the first manifestation of the syndrome. Most infections occurring within the endemic region are caused by exogenous exposure, while those occurring in nonendemic areas may represent endogenous reactivation of latent foci of infection or exogenous exposure to microfoci located within those nonendemic regions. However, prospective investigations are needed to prove the mode of acquisition. The infection usually begins in the lungs even though the chest roentgenogram may be normal. Clinical findings are nonspecific; most patients present with symptoms of fever and weight loss of at least 1 month's duration. When untreated, many cases eventually develop severe clinical manifestations resembling septicemia. Chest roentgenograms, when abnormal, show interstitial or reticulonodular infiltrates. Many cases have been initially misdiagnosed as disseminated mycobacterial infection or Pneumocystis carinii pneumonia. Patients are often concurrently infected with other opportunistic pathogens, supporting the need for a careful search for co-infections. Useful diagnostic tests include serologic tests for anti-H. capsulatum antibodies and HPA, silver stains of tissue sections or body fluids, and cultures using fungal media from blood, bone marrow, bronchoalveolar lavage fluid, and other tissues or body fluids suspected to be infected on clinical grounds. Treatment with amphotericin B is highly effective, reversing the clinical manifestations of infection in at least 80% of cases. However, nearly all patients relapse within 1 year after completing courses of amphotericin B of 35 mg/kg or more, supporting the use of maintenance treatment to prevent recurrence. Relapse rates are lower (9 to 19%) in patients receiving maintenance therapy with amphotericin B given at doses of about 50 mg weekly or biweekly than with ketoconazole (50-60%), but controlled trials comparing different maintenance regimens have not been conducted. Until results of such trials become available, our current approach is to administer an induction phase of 15 mg/kg of amphotericin B given over 4 to 6 weeks, followed by maintenance therapy with 50 to 100 mg of amphotericin B given once or twice weekly, or biweekly. If results of a prospective National Institutes of Allergy and Infectious Disease study of itraconazole maintenance therapy document its effectiveness, alternatives to amphotericin B may be reasonable.

UI MeSH Term Description Entries
D011020 Pneumonia, Pneumocystis A pulmonary disease in humans occurring in immunodeficient or malnourished patients or infants, characterized by DYSPNEA, tachypnea, and HYPOXEMIA. Pneumocystis pneumonia is a frequently seen opportunistic infection in AIDS. It is caused by the fungus PNEUMOCYSTIS JIROVECII. The disease is also found in other MAMMALS where it is caused by related species of Pneumocystis. P carinii Pneumonia,P. carinii Pneumonia,P. jirovecii Pneumonia,PCP Pneumonia,Pneumocystis Pneumonia,Pneumocystosis,Pneumonia, Interstitial Plasma Cell,PCP Infection,Pneumocystis carinii Pneumonia,Pneumocystis jirovecii Pneumonia,Pneumonia, Pneumocystis carinii,Infection, PCP,P carinii Pneumonias,P. carinii Pneumonias,P. jirovecii Pneumonias,PCP Infections,PCP Pneumonias,Pneumocystis Pneumonias,Pneumocystoses,Pneumonia, P carinii,Pneumonia, P. carinii,Pneumonia, P. jirovecii,Pneumonia, PCP,Pneumonia, Pneumocystis jirovecii,Pneumonias, PCP
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D006660 Histoplasmosis Infection resulting from exposure to the fungus HISTOPLASMA. African Histoplasmosis,Disseminated Histoplasmosis,Histoplasma duboisii Infection,Pulmonary Histoplasmosis,Histoplasma Infection,Histoplasma capsulatum Infection,Histoplasma Infections,Histoplasma capsulatum Infections,Histoplasma duboisii Infections,Histoplasmosis, African,Histoplasmosis, Disseminated,Histoplasmosis, Pulmonary,Infection, Histoplasma,Infection, Histoplasma capsulatum,Infection, Histoplasma duboisii
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000666 Amphotericin B Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela. Amphocil,Amphotericin,Amphotericin B Cholesterol Dispersion,Amphotericin B Colloidal Dispersion,Fungizone

Related Publications

L J Wheat, and P A Connolly-Stringfield, and R L Baker, and M F Curfman, and M E Eads, and K S Israel, and S A Norris, and D H Webb, and M L Zeckel
Disseminated histoplasmosis in the acquired immune deficiency syndrome.
November 1984, Archives of internal medicine,
L J Wheat, and P A Connolly-Stringfield, and R L Baker, and M F Curfman, and M E Eads, and K S Israel, and S A Norris, and D H Webb, and M L Zeckel
Disseminated histoplasmosis associated with the acquired immune deficiency syndrome.
September 1984, The American journal of medicine,
L J Wheat, and P A Connolly-Stringfield, and R L Baker, and M F Curfman, and M E Eads, and K S Israel, and S A Norris, and D H Webb, and M L Zeckel
Disseminated histoplasmosis in patients with the acquired immune deficiency syndrome.
November 1984, Archives of internal medicine,
L J Wheat, and P A Connolly-Stringfield, and R L Baker, and M F Curfman, and M E Eads, and K S Israel, and S A Norris, and D H Webb, and M L Zeckel
Progressive disseminated histoplasmosis in patients with the acquired immune deficiency syndrome: a report of 12 cases and a literature review.
March 1986, Seminars in respiratory infections,
L J Wheat, and P A Connolly-Stringfield, and R L Baker, and M F Curfman, and M E Eads, and K S Israel, and S A Norris, and D H Webb, and M L Zeckel
Histoplasmosis in the acquired immune deficiency syndrome.
February 1985, The American journal of medicine,
L J Wheat, and P A Connolly-Stringfield, and R L Baker, and M F Curfman, and M E Eads, and K S Israel, and S A Norris, and D H Webb, and M L Zeckel
Progressive disseminated histoplasmosis in acquired immune deficiency syndrome: presentation as a steroid-responsive dermatosis.
June 1989, Cutis,
L J Wheat, and P A Connolly-Stringfield, and R L Baker, and M F Curfman, and M E Eads, and K S Israel, and S A Norris, and D H Webb, and M L Zeckel
Disseminated African histoplasmosis in a white heterosexual male patient with the acquired immune deficiency syndrome.
October 1987, Mykosen,
L J Wheat, and P A Connolly-Stringfield, and R L Baker, and M F Curfman, and M E Eads, and K S Israel, and S A Norris, and D H Webb, and M L Zeckel
Histoplasmosis in patients with the acquired immune deficiency syndrome.
December 1986, The American journal of medicine,
L J Wheat, and P A Connolly-Stringfield, and R L Baker, and M F Curfman, and M E Eads, and K S Israel, and S A Norris, and D H Webb, and M L Zeckel
Histoplasmosis presenting as pneumoperitoneum in patients with acquired immune deficiency syndrome: case reports and review of the literature.
January 2005, The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society,
L J Wheat, and P A Connolly-Stringfield, and R L Baker, and M F Curfman, and M E Eads, and K S Israel, and S A Norris, and D H Webb, and M L Zeckel
Cutaneous manifestations of histoplasmosis in the acquired immune deficiency syndrome.
February 1993, The American journal of surgical pathology,
Copied contents to your clipboard!